Cargando…

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine

Genetic studies have advanced our understanding of pancreatic cancer at a mechanistic and translational level. Genetic concepts and tools are increasingly starting to be applied to clinical practice, in particular for precision medicine efforts. However, epigenomics is rapidly emerging as a promisin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lomberk, Gwen, Dusetti, Nelson, Iovanna, Juan, Urrutia, Raul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713756/ https://www.ncbi.nlm.nih.gov/pubmed/31462645 http://dx.doi.org/10.1038/s41467-019-11812-7

Ejemplares similares

The promise of epigenomic therapeutics in pancreatic cancer
por: Lomberk, Gwen A, et al.
Publicado: (2016)

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
por: Kaoutari, Abdessamad El, et al.
Publicado: (2021)

Pancreatitis promotes oncogenic Kras(G12D)-induced pancreatic transformation through activation of Nupr1
por: Grasso, Daniel, et al.
Publicado: (2014)

Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2023)

Precision medicine in trauma: a transformational frontier in patient care, education, and research
por: Davis, Christopher Stephen, et al.
Publicado: (2021)

Single and combinatorial chromatin coupling events underlies the function of transcript factor krüppel-like factor 11 in the regulation of gene networks
por: Calvo, Ezequiel, et al.
Publicado: (2014)

Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
por: Juiz, Natalia Anahi, et al.
Publicado: (2019)

Evidence supporting the existence of a NUPR1-like family of helix-loop-helix chromatin proteins related to, yet distinct from, AT hook-containing HMG proteins
por: Urrutia, Raul, et al.
Publicado: (2014)

Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
por: Lomberk, Gwen, et al.
Publicado: (2018)

Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma
por: Santofimia-Castaño, Patricia, et al.
Publicado: (2019)

The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation
por: Loncle, C, et al.
Publicado: (2016)

The Heterochromatin Protein 1 family
por: Lomberk, Gwen, et al.
Publicado: (2006)

Functional impact of Aurora A-mediated phosphorylation of HP1γ at serine 83 during cell cycle progression
por: Grzenda, Adrienne, et al.
Publicado: (2013)

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Drugging the epigenome in the age of precision medicine
por: Feehley, Taylor, et al.
Publicado: (2023)

Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts
por: Bian, Benjamin, et al.
Publicado: (2017)

Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks
por: Urrutia, Guillermo, et al.
Publicado: (2021)

Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression
por: Grzenda, Adrienne, et al.
Publicado: (2013)

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
por: Casolino, R., et al.
Publicado: (2021)

Kras(G12D) induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells
por: Mathison, Angela J., et al.
Publicado: (2021)

Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
por: Cano, Carla E, et al.
Publicado: (2012)

Homotypic cell cannibalism, a cell‐death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
por: Cano, Carla E, et al.
Publicado: (2021)

Emerging Therapies in CLL in the Era of Precision Medicine
por: Iyer, Prajish, et al.
Publicado: (2023)

Krüppel-like Factor 11 Differentially Couples to Histone Acetyltransferase and Histone Methyltransferase Chromatin Remodeling Pathways to Transcriptionally Regulate Dopamine D2 Receptor in Neuronal Cells
por: Seo, Seungmae, et al.
Publicado: (2012)

Mechanisms Underlying the Regulation of HP1γ by the NGF-PKA Signaling Pathway
por: Seo, Seungmae, et al.
Publicado: (2018)

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
por: Sereti, Evangelia, et al.
Publicado: (2023)

Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition
por: Gajate, Consuelo, et al.
Publicado: (2021)

Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation
por: Grasso, Daniel, et al.
Publicado: (2015)

Gastric Cancer in the Era of Precision Medicine
por: Liu, Xi, et al.
Publicado: (2017)

Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma
por: Shoucair, Sami, et al.
Publicado: (2021)

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022)

Inactivation of NUPR1 promotes cell death by coupling ER-stress responses with necrosis
por: Santofimia-Castaño, Patricia, et al.
Publicado: (2018)

Writers and readers of H3K9me2 form distinct protein networks during the cell cycle that include candidates for H3K9 mimicry
por: Pollin, Gareth, et al.
Publicado: (2023)

Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss
por: Kalinec, Gilda M., et al.
Publicado: (2017)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Epigenome engineering: new technologies for precision medicine
por: Sgro, Agustin, et al.
Publicado: (2020)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Modeling post‐translational modifications and cancer‐associated mutations that impact the heterochromatin protein 1α‐importin α heterodimers
por: Zimmermann, Michael T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_svm22tvn541mmn2j6tb270sp5b